Skip to content

Benefit of Virtual Reality in rehabilitation of patients with chronic vertigo/giddiness

Evaluation of Virtual Reality Assisted Therapy as an Adjunct to Conventional Vestibular Rehabilitation Therapy for Chronic Vestibular Hypofunction: A Randomized Controlled Trial - VIRAT (virtual reality assisted therapy)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074962
Enrollment
30
Registered
2024-10-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H818- Other disorders of vestibular function

Interventions

Intervention1: Virtual Reality Assisted Therapy (VRAT): Participants allocated to this treatment arm will receive Virtual Reality (VR) assisted therapy in addition to Conventional VRT. VRAT utilizes i

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Chronic vestibular hypofunction: Duration of vestibular symptoms of 3 months or more 2.Definitive diagnosis of chronic vestibular hypofunction based reduced VOR function documented on one / more of following: a. VOR gain less than 0.6 on video head impulse test b. reduced angular VOR gain (less than 0.1) on sinusoidal acceleration on rotary chair testing (0.16Hz), Vmax 50 degrees/second and phase lead more than 68 degrees, time constant less than 5 seconds c. reduced caloric response, sum of bithermal maximum peak SPV on each side less than 6 degrees/ second, % canal paresis as per Jonkees formula 20% or more

Exclusion criteria

Exclusion criteria: 1. Use of vestibular suppressants in last 72 hours. 2. Diseases with fluctuating vestibulopathy e.g. Meniere’s Disease 3. Already diagnosed clinical psychiatric conditions/ neurodegenerative/ neuromuscular/ musculoskeletal/ motor disorders/ peripheral neuropathy/ arthropathy in lower extremities/ uncorrected ocular disorders that will interfere with performance of rehabilitation exercises 4. Significant medical disorders e.g. severe anaemia, uncontrolled hypertension, cardiorespiratory disorders, epilepsy, vertebro-basilar insufficiency, cervical spondylosis, etc. that may be aggravated by exercises. 5. Pregnant females 6. Inability to follow-up

Design outcomes

Primary

MeasureTime frame
Patient reported outcome measures: Dizziness Handicap Inventory (DHI), Activities-specific Balance Confidence Scale (ABC), Vestibular Rehabilitation Benefit Questionnaire (VRBQ), Visual Vertigo Analogue Scale (VVAS) Clinical assessment tools: Berg Balance Scale, Dynamic Gait Index, Timed up and Go (TUG) test Objective vestibular testing: Video Head Impulse Test, Rotary chair testing, Bithermal Caloric test, Computerized Dynamic Posturography, Craniocorporography Timepoint: 1. Baseline assessment (at presentation) 2. At 6 weeks (at completion of intervention) 3. At 12 weeks (6 weeks post completion of intervention) 4. At 18 weeks (12 weeks post completion of intervention)

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Siddhi Patil

All India Institute of Medical Sciences-Rajkot

grmprt@gmail.com9871252109

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026